Page last updated: 2024-08-25

ketorolac tromethamine and Disease Exacerbation

ketorolac tromethamine has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dominguez, D; Grimes, MM; Hathaway, HJ; Hudson, LG; Kusewitt, DF; Peretti, AS; Prossnitz, ER; Rivera, MR; Wandinger-Ness, A1
Ohno-Matsui, K; Vutipongsatorn, K; Yokoi, T1
Avila-Vazquez, M; Bergel, E; Cafferata, ML; De Alvarez, BV; Franco, M; Maffrand, R; Sosa, M1

Reviews

1 review(s) available for ketorolac tromethamine and Disease Exacerbation

ArticleYear
Current and emerging pharmaceutical interventions for myopia.
    The British journal of ophthalmology, 2019, Volume: 103, Issue:11

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Clinical Trials as Topic; Disease Progression; Drug Evaluation, Preclinical; Drug Therapy; Humans; Ketorolac Tromethamine; Mydriatics; Myopia; Pharmaceutical Preparations; Riboflavin; Vitamin B Complex; Xanthines

2019

Trials

1 trial(s) available for ketorolac tromethamine and Disease Exacerbation

ArticleYear
Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study.
    BMC pediatrics, 2004, Aug-07, Volume: 4

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Argentina; Cohort Studies; Comorbidity; Disease Progression; Female; Humans; Incidence; Infant, Newborn; Infant, Premature; Ketorolac Tromethamine; Male; Ophthalmic Solutions; Oxygen Inhalation Therapy; Retinopathy of Prematurity; Treatment Outcome

2004

Other Studies

1 other study(ies) available for ketorolac tromethamine and Disease Exacerbation

ArticleYear
The R-Enantiomer of Ketorolac Delays Mammary Tumor Development in Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) Mice.
    The American journal of pathology, 2018, Volume: 188, Issue:2

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Differentiation; Cell Proliferation; Disease Progression; Drug Administration Schedule; Drug Evaluation, Preclinical; Epithelial Cells; Female; Ketorolac Tromethamine; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Mice, Transgenic; Polyomavirus

2018